115 related articles for article (PubMed ID: 1977399)
21. Biochemical detection and monitoring of alcohol abuse and abstinence.
Sharpe PC
Ann Clin Biochem; 2001 Nov; 38(Pt 6):652-64. PubMed ID: 11732647
[TBL] [Abstract][Full Text] [Related]
22. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
[TBL] [Abstract][Full Text] [Related]
23. Plasma-HDL-cholesterol and estimated ethanol consumption in 104 patients with alcohol dependence syndrome.
Bell H; Strømme JH; Steensland H; Bache-Wiig JE
Alcohol Alcohol; 1985; 20(1):35-40. PubMed ID: 2861825
[TBL] [Abstract][Full Text] [Related]
24. [Persons with known alcohol problems. Screening procedures for alcohol consumption].
Duckert F; Amundsen A; Johnsen J; Mørland J; Strømme JH
Tidsskr Nor Laegeforen; 1987 Jan; 107(1):62-5. PubMed ID: 2881372
[No Abstract] [Full Text] [Related]
25. [Urinary beta-hexosaminidase activity as a marker for the monitoring of sobriety].
Wehr H; Habrat B; Czartoryska B; Górska D; Woronowicz B
Psychiatr Pol; 1995; 29(5):689-96. PubMed ID: 8577909
[TBL] [Abstract][Full Text] [Related]
26. Combining the audit questionnaire and biochemical markers to assess alcohol use and risk of alcohol withdrawal in medical inpatients.
Dolman JM; Hawkes ND
Alcohol Alcohol; 2005; 40(6):515-9. PubMed ID: 16103035
[TBL] [Abstract][Full Text] [Related]
27. Laboratory tests in the follow-up of treated alcoholics: how often should testing be repeated?
Keso L; Salaspuro M
Alcohol Alcohol; 1990; 25(4):359-63. PubMed ID: 1977398
[TBL] [Abstract][Full Text] [Related]
28. Combining markers of nephrotoxicity and hepatotoxicity for improved monitoring and detection of chronic alcohol abuse.
Taracha E; Habrat B; Chrapusta SJ; Lehner M; Wisłowska A; Woronowicz BT; Bogulas M; Charewicz J; Markuszewski C; Płaźnik A
Clin Chem Lab Med; 2006; 44(12):1446-52. PubMed ID: 17163821
[TBL] [Abstract][Full Text] [Related]
29. [Enzyme diagnostic criteria of alcoholism].
Piatnitskaia IN; Chernobrovkina TV; Goriushkin II
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(7):1051-3. PubMed ID: 2863908
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of apolipoprotein E (apoE) and lipoprotein profile in severe alcohol-dependent individuals.
Liappas IA; Nikolaou C; Michalopoulou M; Paparrigopoulos T; Tzavellas EO; Piperi C; Cambouri C; Soldatos CR
In Vivo; 2007; 21(4):699-702. PubMed ID: 17708369
[TBL] [Abstract][Full Text] [Related]
31. Laboratory markers as compared to drinking measures before and after inpatient treatment for alcoholism.
Keso L; Salaspuro M
Alcohol Clin Exp Res; 1989 Jun; 13(3):449-52. PubMed ID: 2568766
[TBL] [Abstract][Full Text] [Related]
32. Vitamin B12 and hepatic enzyme serum levels correlate with interleukin-6 in alcohol-dependent individuals without liver disease.
Liappas IA; Nicolaou C; Chatzipanagiotou S; Tzavellas EO; Piperi C; Papageorgiou C; Boufidou F; Bagos P; Soldatos CR
Clin Biochem; 2007 Jul; 40(11):781-6. PubMed ID: 17442294
[TBL] [Abstract][Full Text] [Related]
33. Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study.
Anton RF; Lieber C; Tabakoff B;
Alcohol Clin Exp Res; 2002 Aug; 26(8):1215-22. PubMed ID: 12198396
[TBL] [Abstract][Full Text] [Related]
34. The early detection of heavy alcohol consumption using routine clinical laboratory test results.
Harasymiw J
Am Clin Lab; 2002 Jul; 21(6):22-4. PubMed ID: 12224178
[No Abstract] [Full Text] [Related]
35. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
[TBL] [Abstract][Full Text] [Related]
36. Gamma-glutamyltranspeptidase, aspartate aminotransferase, and erythrocyte mean corpuscular volume as indicators of alcohol consumption in liver disease.
Eriksen J; Olsen PS; Thomsen AC
Scand J Gastroenterol; 1984 Sep; 19(6):813-9. PubMed ID: 6151242
[TBL] [Abstract][Full Text] [Related]
37. Biological markers of alcohol consumption and effect of calcitonin in nonalcoholic men: a prospective, double-blind study.
Elomaa VV; Löyttyniemi E; Kãrkkäinen P; Salaspuro M; Laitinen K
Alcohol Clin Exp Res; 1996 Aug; 20(5):830-5. PubMed ID: 8865956
[TBL] [Abstract][Full Text] [Related]
38. Effects of moderate drinking and alcohol abstinence on urinary dolichol levels.
Roine RP
Alcohol; 1988; 5(3):229-31. PubMed ID: 2901264
[TBL] [Abstract][Full Text] [Related]
39. [Low T4 syndrome in alcoholism: role of the decrease in TBG].
Grimaldi F; De Marchi S; Cecchin E
Minerva Med; 1986 Mar; 77(11):381-5. PubMed ID: 2871525
[TBL] [Abstract][Full Text] [Related]
40. [Value of determining gamma-glutamyltransferase, alkaline phosphatase and aspartate and alanine aminotransferase activities in the evaluation of liver damage in alcoholics].
Laskus T; Szczutowska E; Babiuch L; Poplewska M; Mormul E
Pol Tyg Lek; 1988 Apr; 43(14):438-40. PubMed ID: 2901075
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
